Microfluidic organ-on-a-chip models of human liver tissue
Source abstract
Abstract
The liver is the largest internal organ of the body with complex microarchitecture and function that plays critical roles in drug metabolism. Hepatotoxicity and drug-induced liver injury (DILI) caused by various drugs is the main reason for late-stage drug failures. Moreover, liver diseases are among the leading causes of death in the world, with the number of new cases arising each year. Although animal models have been used to understand human drug metabolism and toxicity before clinical trials, tridimensional microphysiological systems, such as liver-on-a-chip (Liver Chip) platforms, could better recapitulate features of human liver physiology and pathophysiology and thus, are often more predictive of human outcome. Liver Chip devices have shown promising results in mimicking in vivo condition by recapitulating the sinusoidal structure of the liver, maintaining high cell viability and cellular phenotypes, and emulating native liver functions. Here, we first review the cellular constituents and physiology of the liver and then critically discuss the state-of-the-art chip-based liver models and their applications in drug screening, disease modeling, and regenerative medicine. We finally address the pending issues of existing platforms and touch upon future directions for developing new, advanced on-chip models.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Liver physiology and pathology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Anatomy and cellular functions of the liver
2. A.L. Mescher, L.C.U. Junqueira, Junqueira's basic histology: text and atlas, (2016).
3. Chip-based liver equivalents for toxicity testing–organotypicalness versus cost-efficient high throughput10.1039/c3lc50240f ↗
4. Organotypic liver culture models: Meeting current challenges in toxicity testing10.3109/10408444.2012.682115 ↗
5. Microengineered cell and tissue systems for drug screening and toxicology applications: evolution of in-vitro liver technologies10.1142/S2339547815300012 ↗
6. Chapter 14 - microfluidic hepatotoxicity platform
7. Liver sinusoidal endothelial cells10.1002/j.2040-4603.2015.tb00660.x ↗
8. Seven steps to stellate cells
9. Kupffer cells
10. Hepatic stellate cells as key target in liver fibrosis10.1016/j.addr.2017.05.007 ↗
11. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis10.1016/j.yexcr.2017.02.038 ↗
12. Chapter 44 - Physiology of Cholngiocytes
13. Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review10.3390/mi10100676 ↗
14. A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction10.1063/1.5070088 ↗
15. Polyploidization of liver cells
16. In Vitro Platforms for Evaluating Liver Toxicity10.1177/1535370214531872 ↗
17. Engineering a perfusable 3D human liver platform from iPS cells10.1039/C6LC00598E ↗
18. Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury10.3389/fphar.2019.01093 ↗
19. Liver microphysiological systems for predicting and evaluating drug effects10.1002/cpt.1458 ↗
20. A bioprinted liver-on-a-chip for drug screening applications10.1016/j.tibtech.2016.05.014 ↗
21. Multi-cellular 3D human primary liver cell cultures elevate metabolic activity under fluidic flow10.1039/C5LC00237K ↗
22. Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans
23. Novel in vitro and mathematical models for the prediction of chemical toxicity10.1039/C2TX20031G ↗
24. Bioengineered liver models for drug testing and cell differentiation studies10.1016/j.jcmgh.2017.11.012 ↗
25. Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation10.1002/hep.28780 ↗
26. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation10.1002/hep.26414 ↗
27. 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip10.1039/C5LC00611B ↗
28. Microfluidic Platforms for Hepatocyte Cell Culture: New Technologies and Applications10.1007/s10439-011-0453-8 ↗
29. Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform10.1039/C4LC00071D ↗
30. Recent advances in three-dimensional multicellular spheroid culture for biomedical research10.1002/biot.200700228 ↗
31. Microfluidic devices as tools for mimicking the in vivo environment10.1039/c0nj00709a ↗
32. Engineering tumors with 3D scaffolds10.1038/nmeth1085 ↗
33. 3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism, and toxicity: emerging culture paradigms and applications10.1002/biot.201800347 ↗
34. Biological nanofactories facilitate spatially selective capture and manipulation of quorum sensing bacteria in a bioMEMS device10.1039/b926846d ↗
35. Lin · 2017
36. Microfluidic technology in vascular research
37. Metabolomics-on-a-Chip and predictive systems toxicology in microfluidic bioartificial organs10.1021/ac2011075 ↗
38. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips10.3109/00498254.2012.706725 ↗
39. An Orally Active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure10.1126/scitranslmed.3004276 ↗
40. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer10.1016/j.biomaterials.2013.02.045 ↗
41. Organ-on-a-chip technology: turning its potential for clinical benefit into reality10.1016/j.drudis.2019.03.011 ↗
42. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
43. Organ-on-a-chip: recent breakthroughs and future prospects10.1186/s12938-020-0752-0 ↗
44. Drug toxicity evaluation based on organ-on-a-chip technology: a review
45. Challenges and opportunities in the design of liver-on-chip microdevices10.1146/annurev-bioeng-060418-052305 ↗
46. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture10.1002/bit.21360 ↗
47. Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor10.1016/j.bej.2010.10.007 ↗
48. An in vitro liver model on microfluidic device for analysis of capecitabine metabolite using mass spectrometer as detector10.1016/j.bios.2015.01.013 ↗
49. Liver-cell patterning Lab Chip: mimicking the morphology of liver lobule tissue10.1039/c3lc50402f ↗
50. Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform
51. A microfluidic device mimicking acinar concentration gradients across the liver acinus10.1007/s10544-013-9762-z ↗
52. Liver sinusoid on a chip: Long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic platforms10.1002/bit.25659 ↗
53. Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip10.1039/C6LC01374K ↗
54. Long Term Maintenance of a Microfluidic 3-D Human Liver Sinusoid10.1002/bit.25700 ↗
55. A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity10.1142/S2339547815200034 ↗
56. Metabolic patterning on a chip: towards in vitro liver zonation of primary rat and human hepatocytes10.1038/s41598-018-27179-6 ↗
57. A Microfabricated Platform for Generating Physiologically-Relevant Hepatocyte Zonation10.1038/srep26868 ↗
58. Liver ‘organ on a chip’10.1016/j.yexcr.2017.12.023 ↗
59. Layered patterning of hepatocytes in co-culture systems using microfabricated stencils10.2144/000113317 ↗
60. Microfluidic synthesis of pure chitosan microfibers for bio-artificial liver chip10.1039/b924987g ↗
61. Reconstruction of 3D stacked-up structures by rat small hepatocytes on microporous membranes10.1096/fj.04-3269fje ↗
62. Membrane-Based PDMS Microbioreactor for Perfused 3D Primary Rat Hepatocyte Cultures10.1023/B:BMMD.0000048560.96140.ca ↗
63. Hepatocytes enhance effects of lipopolysaccharide on liver nonparenchymal cells through close cell interactions10.1097/01.shk.0000160939.08385.f1 ↗
64. Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions10.1002/bit.20086 ↗
65. Longterm stability of phase I and phase II enzymes of porcine liver cells in flat membrane bioreactors10.1002/bit.1151 ↗
66. Lab on a chip-based hepatic sinusoidal system simulator for optimal primary hepatocyte culture10.1007/s10544-016-0079-6 ↗
67. Effect of tissue-culture substratum and extracellular matrix overlay on liver-selective and xenobiotic inducible gene expression in primary rat hepatocytes
68. A novel ultrathin collagen nanolayer assembly for 3-D microtissue engineering: Layer-by-layer collagen deposition for long-term stable microfluidic hepatocyte culture10.1142/S2339547814500083 ↗
69. What is normal intra-abdominal pressure and how is it affected by positioning, body mass and positive end-expiratory pressure?10.1007/s00134-009-1445-0 ↗
70. A vertical-flow bioreactor array compacts hepatocytes for enhanced polarity and functions10.1039/C6LC00811A ↗
71. Hepatocyte polarity10.1002/j.2040-4603.2013.tb00490.x ↗
72. Mechanical compaction directly modulates the dynamics of bile canaliculi formation10.1039/C2IB20229H ↗
73. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems10.1093/toxsci/kfg064 ↗
74. Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device10.1063/1.3580753 ↗
75. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration10.1021/bp00009a007 ↗
76. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration10.1096/fasebj.10.13.8940293 ↗
77. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids10.1006/excr.2001.5467 ↗
78. Integration of technologies for hepatic tissue engineering
79. Familial intrahepatic cholestasis 1: studies of localization and function10.1053/jhep.2001.27663 ↗
80. Modulation of multidrug resistance-associated Protein 2 (Mrp2) and Mrp3 expression and function with small interfering RNA in Sandwich-Cultured Rat Hepatocytes10.1124/mol.66.4.1004 ↗
81. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins10.1007/s10565-011-9208-4 ↗
82. Microfluidic devices for in vitro studies on liver drug metabolism and toxicity10.1039/c0ib00119h ↗
83. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes10.1124/dmd.110.035873 ↗
84. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity10.1002/bit.22366 ↗
85. Towards a human-on-chip: Culturing multiple cell types on a chip with compartmentalized microenvironments10.1039/b915147h ↗
86. Flow-based three-dimensional co-culture model for long-term hepatotoxicity prediction
87. Improvement of HepG2/C3a cell functions in a microfluidic biochip10.1002/bit.23104 ↗
88. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor10.1002/bit.1071 ↗
89. On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro10.1063/1.4922863 ↗
90. Phaseguides: a paradigm shift in microfluidic priming and emptying10.1039/c0lc00643b ↗
91. Microfluidic titer plate for stratified 3D cell culture10.1039/c3lc50210d ↗
92. Computational fluid model incorporating liver metabolic activities in perfusion bioreactor10.1002/bit.25157 ↗
93. Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels10.1088/1758-5082/6/2/024105 ↗
94. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
95. A liver-on-a-chip platform with bioprinted hepatic spheroids
96. The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics10.1016/j.cbi.2006.12.003 ↗
97. In vitro and in silico liver models: Current trends, challenges and opportunities10.14573/altex.1803221 ↗
98. A microfluidically perfused three dimensional human liver model10.1016/j.biomaterials.2015.08.043 ↗
99. Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB110.1242/jcs.068098 ↗
100. Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip10.1002/term.2802 ↗